Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Transportation, E-Commerce & Mechanical Systems
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
BGI GENOMICS CO., LTD. has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 2 examiners and 2 art units, indicating distributed prosecution across separate technical settings.
PAK, YONG D is the busiest examiner, with 1 pending matter. Examiner-specific review will help distinguish the issues while maintaining consistency across the portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PAK, YONG D | 1 | 74.7% | +14.2% |
| LEE, GILBERT Y | 1 | 78.8% | +10.7% |
| KWAK, DEAN P | 1 | 58.8% | +37.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18723633 | HELICASE BCH2X AND USE THEREOF | PAK, YONG D | — |
| 18711898 | SEALING DEVICE AND SEALING SYSTEM | LEE, GILBERT Y | — |
| 18711641 | MICROFLUIDIC DEVICE AND MICROFLUIDIC DETECTION DEVICE | KWAK, DEAN P | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18723633 | HELICASE BCH2X AND USE THEREOF | PAK, YONG D | — |
| 18711898 | SEALING DEVICE AND SEALING SYSTEM | LEE, GILBERT Y | — |
| 18711641 | MICROFLUIDIC DEVICE AND MICROFLUIDIC DETECTION DEVICE | KWAK, DEAN P | — |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| 3675 | 1 |
| 1798 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18723633 | HELICASE BCH2X AND USE THEREOF | PAK, YONG D | 1652 | §101§112 | Final Rejection | — | Pending | Jun 24, 2024 |
| 18711898 | SEALING DEVICE AND SEALING SYSTEM | LEE, GILBERT Y | 3675 | §102§103 | Non-Final OA | — | Pending | May 21, 2024 |
| 18711641 | MICROFLUIDIC DEVICE AND MICROFLUIDIC DETECTION DEVICE | KWAK, DEAN P | 1798 | §102§112 | Non-Final OA | — | Pending | May 20, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBGI GENOMICS CO., LTD. has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Yong D Pak has the most, with 1 of BGI GENOMICS CO., LTD.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
